Skip to main content

Anti-obesity drugs: Public skepticism surrounds long-term safety, tolerability

By Claire Bugos* 

When Ozempic and Mounjaro were approved to treat diabetes, they also ushered in a wave of opportunity for obesity medicine. This new class of drugs, called glucagon-like peptide (GLP-1) receptor agonists, has proven remarkably effective at promoting weight loss and other health outcomes. These drugs have become so hyped that some even claim it could bring about the end of the “obesity epidemic.”
For people living with obesity, however, the GLP-1 drugs hold promise for just one aspect of a larger treatment landscape riddled with challenges.
To understand patient perspectives, Verywell Health surveyed 2,016 adults who identify as obese, overweight, or larger-bodied. The survey explored their weight management experiences and interactions with healthcare providers.
While a majority of respondents seek regular health care and report positive relationships with their providers, many also encounter barriers to care. These obstacles can range from an ill-fitting gown to experiences of subtle or overt judgment from providers. Sometimes, a single negative experience in a medical setting can deter someone from seeking necessary health care.
Obesity drugs like Zepbound and Wegovy are the most effective obesity medications available today, and they’re changing the public conversation about weight management. However, most respondents are either unaware of these drugs or don’t use them. Improving obesity care will require more than introducing novel treatments, the Verywell survey shows.
“[GLP-1 drugs are] not going to make heavier people feel more respected,” said Sean Phelan, PhD, a professor of health services research at the Mayo Clinic who specializes in the impact of stereotyping, prejudice, and discrimination on the health care of people with obesity.
“It's almost easy to default to, ‘If they just take these drugs, then their [health] problems will go away.’ That’s a short-sighted view,” Phelan added. “It’s a very stigmatized group that is really poorly treated in society—that includes in the healthcare system and publicly. The impact of these drugs shouldn’t overshadow the very basic, fundamental truth that people—regardless of what kind of care they seek—deserve the highest quality care.”

If GLP-1s work, why don't more people want them?

For people who have struggled to lose weight through diet and exercise, having access to GLP-1s can be really helpful, Phelan said. These drugs acknowledge that, in some ways, their large body may be the result of biological factors. Deploying a treatment can help alleviate the personal shame and responsibility that some people may feel about their weight, he said.
In clinical trials, the most potent GLP-1s can help people lose more than 20% of their body weight. Newer research indicates they can even protect against heart disease and liver disease, as well as relieve symptoms of conditions like sleep apnea and addiction.
No medication works for everyone, however. For instance, about 15% of people won’t lose any meaningful weight on Eli Lilly’s Zepbound even at the highest dose.
“For those who are responders, [GLP-1s] can be highly effective,” said Fatima Cody Stanford, MD, MPH, MPA, an obesity medicine physician-scientist and associate professor of medicine at Massachusetts General Hospital and Harvard Medical School. “But can you imagine if you come in thinking these are going to change your life, and you’re not in that group?”
Public skepticism also surrounds the long-term safety and tolerability of the GLP-1 drugs. The Verywell survey respondents echoed that wariness: Less than a third of them perceive the drugs to be safe.
GLP-1s must be taken perpetually to maintain weight loss. But among the survey respondents who have taken them, more than a quarter plan to stop using them within a year, and more than half have already discontinued use.
Some patients may stop taking the drugs because of uncomfortable side effects or poor results. Stanford said it’s important to work with an experienced obesity medicine provider who prioritizes long-term health outcomes rather than rapid weight loss.
“I don’t see [GLP-1s] as this panacea,” Stanford said. “I see them as a very useful tool among other tools to treat patients with obesity. You need a skilled clinician to choose to use these, and I think we have a lot of unskilled clinicians using these medications.”

What weight bias looks like at the doctor's office

Even with the right treatment plan, social factors can influence a patient’s experience with weight management.
From the moment a patient walks into a doctor’s office, they receive a message about how welcome they are—or not. It can be demoralizing to arrive in a waiting room with chairs that are too small for their body, or to sit in a doctor’s office while the provider hastens to get a blood pressure cuff that will fit, said Erin Harrop, LICSW, PhD, an assistant professor at the University of Denver and a licensed medical social worker whose research specializes in weight stigma and patient-provider communication.
Nearly a third of the Verywell survey respondents said they've had difficulty accessing size-appropriate medical gowns, medical devices, or examination tables. A quarter of respondents said they've stepped backward on a scale or asked not to be weighed in a medical visit.
Phelan’s research shows that people in larger bodies are likely to be told to lose weight as a first step in most medical interventions, regardless of their specific health concerns. The biggest barrier to care for most people, he said, is finding a provider who aligns with their goals.
Weight loss isn’t always the answer to a health problem. Nearly a third of respondents said losing weight wouldn’t necessarily make them healthier, and a quarter said their size wasn’t preventing them from being healthy.
While GLP-1s can be helpful for some patients who seek to lose weight, an often-overlooked conversation is whether they reinforce the notion that smaller is better.
“There are people who feel good about living in a larger body, and for them, it’s part of their identity. It’s not something that they want to change,” Phelan said. “For those people, the existence of a drug whose target is to eliminate that identity, eliminate that part of their life, can be really threatening.”
Harrop added that people can generally gauge their own health pretty well.
“I’m in a ‘class three obese’ body right now. My blood pressure is well managed. My blood sugar is well managed. I’m an athlete—I play competitive volleyball at the university down the street,” Harrop said. “If you were to look at my chart, it would say, ‘Erin has obesity—this disease.’ I’m actually quite a healthy person in a larger body size.”
They said when health providers “get distracted” by a person’s weight, they may fail to address their true medical needs, whether it’s a knee replacement, gender-affirming care, migraine management, or another problem that may be unrelated to weight.
“Sometimes we hold the medical treatment hostage in hopes that it will motivate someone to pursue weight loss,” Harrop said.

Weight stigma takes a health toll

Three-quarters of young respondents in the Verywell survey said they’ve been told to lose weight by a friend or family member. More than a third of respondents said people who comment on their weight act with good intentions, but a similar portion also said those comments are unhelpful.
Stanford said even when someone believes they’re well adjusted to negative comments about their body and can just shake it off, the body tells a different story.
Her research shows that those who receive negative comments about their size have an increase in blood sugar, C-reactive protein, and cortisol and other stress hormones. Stress is related to binge eating, increased caloric consumption, maladaptive weight control, and a lower motivation for exercise. Those physiological changes can make it even harder for someone to control their health and weight.
“If stigma is coming from a healthcare provider, you can imagine that’s going to affect healthcare services, and they’re going to have poor treatment adherence,” Stanford said. “Would you want to come and see me if I caused some type of negative reaction? Would you trust me as the healthcare provider? Would you want to come and see me as a follow-up? Probably not.”
Fear of facing repeat stigma and discrimination can stop someone from seeking medical support. More than half of those in our survey who experienced size-based discrimination started going to the doctor less often, delayed a decision, or stopped treatment.
Phelan said those behaviors can be so entrenched in society and medicine that bigger people may not realize that they’re experiencing overt discrimination.
“I don’t know how good we are at identifying all the different ways that discrimination or poor treatment can work their way in. I think we’re really used to it. People get used to a tough love message,” Phelan said.

Small changes make obesity care more inclusive

A good starting point to make healthcare spaces more inclusive is to offer tools that accommodate the needs of the more than 40% of American adults with obesity, according to Stanford. That includes stocking large blood pressure cuffs and patient gowns in each exam room and increasing the number of larger exam tables in each hospital.
Beyond increasing accessibility, Stanford said long-term efforts to root out weight bias and stigma must focus on improving medical provider education.
“If you as a healthcare provider are not treating the person that’s sitting across from you exactly how you want to be treated, you are failing the patient,” she said.
Harrop suggested that another way to make health spaces more comfortable is to only measure a patient’s weight when it’s truly helpful and necessary.
This shift in approach aligns with the changing attitudes toward weight, especially among younger generations. Nearly half of Gen Z survey respondents refused to be weighed, stepped on a scale backward, or asked not to know their weight during a health visit. Only 8% of Boomers said the same.
“Starting from young ages, teach children things like how to take care of their bodies and how to tell if they're hungry or full. These are skills that fat children are trained out of, because they’re taught to distrust their body. They’re taught to rely on calculators and meal plans instead of tuning into their body’s wisdom,” Harrop said.
When attempting to dismantle anti-fat bias, Harrop said it’s not enough to just acknowledge that obesity is multifactorial. They made an analogy to disabilities: Someone who developed a disability because of sports injuries should not receive less accommodation than someone who was in a tragic car accident. An inclusive health system would tend to them both.
“If we only accommodate the people that we consider deserving in their illness, that’s a really dangerous line,” Harrop said. “It’s not enough to just say, ‘People don’t choose to be fat’ or ‘There are biological forces at play.’ The real message needs to be that everybody, no matter what size, deserves good, ethical, efficacious care.”

Methodology

Verywell Health surveyed 2,016 adults living in the U.S. from January 29 to February 7, 2024. The survey was fielded online via a self-administered questionnaire to an opt-in panel of respondents from a market research vendor. In order to qualify, respondents must have identified themselves as any of the following: overweight, obese, fat, person of size, or larger-bodied. Quotas were implemented in sampling using benchmarks from American Community Survey (ACS) from the U.S. Census Bureau for region, age, race/ethnicity, and household income.
---
*Senior News Reporter; expertise: health and science, education, Northwestern University Medill School of Journalism. Factcheck by Nick Blackmer. Illustrations by Julie Bang. Consultation in survey development and design by Daphna Harel, PhD. Research analysis by Amanda Morelli. Story edited by Daphne Lee and Anisa Arsenault. Additional edits by Mackenzie Price, PhD and Shamard Charles, MD, MPH. Source: Verywell Health

Comments

TRENDING

Whither space for the marginalised in Kerala's privately-driven townships after landslides?

By Ipshita Basu, Sudheesh R.C.  In the early hours of July 30 2024, a landslide in the Wayanad district of Kerala state, India, killed 400 people. The Punjirimattom, Mundakkai, Vellarimala and Chooralmala villages in the Western Ghats mountain range turned into a dystopian rubble of uprooted trees and debris.

Advocacy group decries 'hyper-centralization' as States’ share of health funds plummets

By A Representative   In a major pre-budget mobilization, the Jan Swasthya Abhiyan (JSA), India’s leading public health advocacy network, has issued a sharp critique of the Union government’s health spending and demanded a doubling of the health budget for the upcoming 2026-27 fiscal year. 

Iswar Chandra Vidyasagar’s views on religion as Tagore’s saw them

By Harasankar Adhikari   Religion has become a visible subject in India’s public discourse, particularly where it intersects with political debate. Recent events, including a mass Gita chanting programme in Kolkata and other incidents involving public expressions of faith, have drawn attention to how religion features in everyday life. These developments have raised questions about the relationship between modern technological progress and traditional religious practice.

Stands 'exposed': Cavalier attitude towards rushed construction of Char Dham project

By Bharat Dogra*  The nation heaved a big sigh of relief when the 41 workers trapped in the under-construction Silkyara-Barkot tunnel (Uttarkashi district of Uttarakhand) were finally rescued on November 28 after a 17-day rescue effort. All those involved in the rescue effort deserve a big thanks of the entire country. The government deserves appreciation for providing all-round support.

Election bells ringing in Nepal: Can ousted premier Oli return to power?

By Nava Thakuria*  Nepal is preparing for a national election necessitated by the collapse of KP Sharma Oli’s government at the height of a Gen Z rebellion (youth uprising) in September 2025. The polls are scheduled for 5 March. The Himalayan nation last conducted a general election in 2022, with the next polls originally due in 2027.  However, following the dissolution of Nepal’s lower house of Parliament last year by President Ram Chandra Poudel, the electoral process began under the patronage of an interim government installed on 12 September under the leadership of retired Supreme Court judge Sushila Karki. The Hindu-majority nation of over 29 million people will witness more than 3,400 electoral candidates, including 390 women, representing 68 political parties as well as independents, vying for 165 seats in the 275-member House of Representatives.

Jayanthi Natarajan "never stood by tribals' rights" in MNC Vedanta's move to mine Niyamigiri Hills in Odisha

By A Representative The Odisha Chapter of the Campaign for Survival and Dignity (CSD), which played a vital role in the struggle for the enactment of historic Forest Rights Act, 2006 has blamed former Union environment minister Jaynaynthi Natarjan for failing to play any vital role to defend the tribals' rights in the forest areas during her tenure under the former UPA government. Countering her recent statement that she rejected environmental clearance to Vendanta, the top UK-based NMC, despite tremendous pressure from her colleagues in Cabinet and huge criticism from industry, and the claim that her decision was “upheld by the Supreme Court”, the CSD said this is simply not true, and actually she "disrespected" FRA.

Zhou Enlai: The enigmatic premier who stabilized chaos—at what cost?

By Harsh Thakor*  Zhou Enlai (1898–1976) served as the first Premier of the People's Republic of China (PRC) from 1949 until his death and as Foreign Minister from 1949 to 1958. He played a central role in the Chinese Communist Party (CCP) for over five decades, contributing to its organization, military efforts, diplomacy, and governance. His tenure spanned key events including the Long March, World War II alliances, the founding of the PRC, the Korean War, and the Cultural Revolution. 

Pairing not with law but with perpetrators: Pavlovian response to lynchings in India

By Vikash Narain Rai* Lynch-law owes its name to James Lynch, the legendary Warden of Galway, Ireland, who tried, condemned and executed his own son in 1493 for defrauding and killing strangers. But, today, what kind of a person will justify the lynching for any reason whatsoever? Will perhaps resemble the proverbial ‘wrong man to meet at wrong road at night!’

Delhi Jal Board under fire as CAG finds 55% groundwater unfit for consumption

By A Representative   A Comptroller and Auditor General (CAG) of India audit report tabled in the Delhi Legislative Assembly on 7 January 2026 has revealed alarming lapses in the quality and safety of drinking water supplied by the Delhi Jal Board (DJB), raising serious public health concerns for residents of the capital.